On November 16, 2023, the FDA approved capivasertib (Truqap™, AstraZeneca Pharmaceuticals) in combination with fulvestrant (Faslodex®) and a companion diagnostic...
Our newest Metastatic Trial Search partner is Guiding Researchers and Advocates to Scientific Partnerships (GRASP). This organization aims to connect patient...
Our newest Metastatic Trial Search partner is Unite for HER. This organization provides integrative therapies such as nutrition, acupuncture, massage, yoga, and...
The 2023 European Society for Medical Oncology (ESMO) meeting was held October 20-24, 2023 in Madrid, Spain. Click the links below to read about MBC research...
Biomarkers are genes, molecules, or other features present in a person, including in a person’s tumor, that tell doctors something about a person’s health...
Black women and white women are diagnosed with breast cancer at a similar rate. However, Black women are more likely to be diagnosed with an aggressive form of...
As highlighted at the Metastatic Breast Cancer Research Conference 2023, people with MBC can provide hope for other people with MBC by donating their tissue to...
We are excited to announce that Metastatic Trial Search now includes a series of 10 brand-new tutorial videos covering the following topics: Introduction...